Paxlovid, an antiviral against Covid still too little prescribed

Covid cases and hospitalizations have been on the rise for the past fortnight.

To cope with this new wave, vaccination remains more relevant than ever.

But it has been a few months since the vaccine is no longer the only way to fight against serious forms of the disease: since last January, treating physicians can indeed prescribe an antiviral, Paxlovid, in patients at risk of a serious form. of the disease.

But too few still benefit from it…

To discover

• OUR FILE - Tobacco: how to get out of it?

Between February and October 2022, 54,200 people were prescribed this drug, according to the latest data from the public structure of expertise in the epidemiology of health products Epi-Phare, published on Monday.

A use that quadrupled between July and October compared to the period from February to June.

But, if the prescriptions increase sharply, they remain well below the level they should reach.

This article is for subscribers only.

You have 77% left to discover.

Black-Friday

-70% on digital subscription

I ENJOY IT

Already subscribed?

Login